CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • CRI Funded Scientist

    Yifat Merbl, PhD

    Cellular proteasomes are considered the main compartment for protein degradation, and may be considered as the cellular…
  • Iliyan D. Iliev

    CRI Funded Scientist

    Iliyan D. Iliev, PhD

    Cancer is among the leading causes of death worldwide and host-bacterial microbiota immune interactions profoundly influence tumorigenesis,…
  • CRI Funded Scientist

    Matthew H. Spitzer, PhD

    While much of cancer immunology focuses on the tumor environment itself—and rightly so—cancer also affects immune cells…
  • Kole T. Roybal

    CRI Funded Scientist

    Kole T. Roybal, PhD

    Engineered T cell therapies for cancer suffer from a spectrum of deficiencies in solid malignancies. These range…
  • CRI Funded Scientist

    Liang Chi, PhD

    Sex differences in the immune system are associated with higher susceptibility to numerous infectious diseases and cancers…
  • CRI Funded Scientist

    Qiao Lu, PhD

    As the self-derived “demon,” tumor cells can grow uncontrollably and actively suppress T cells, one of the…
  • CRI Funded Scientist

    Rui Miao, PhD

    Cancer immunotherapy, which takes advantage of the patient’s own immune system to fight cancer, has achieved great…
  • Nadav Brandes

    CRI Funded Scientist

    Nadav Brandes, PhD

    One of the most important breakthroughs in treating cancer has been the engineering of immune cells to…
  • CRI Funded Scientist

    Michelle L. Hess, PhD

    Our immune system is designed to recognize and eliminate cancer cells through the same mechanisms as it…
Previous Page
1 … 22 23 24 25 26 … 29
Next Page
Father and son

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

See ways to give

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2026, Cancer Research Institute